Literature DB >> 16249116

Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.

Márcio Diniz-Freitas1, Tomás García-Caballero, José Antúnez-López, José Manuel Gándara-Rey, Abel García-García.   

Abstract

The aim was to evaluate E-cadherin expression in oral squamous cell carcinoma, and its possible relationships with tumour histology and with clinical course and survival. Surgical biopsies from 47 cases of oral squamous cell carcinoma were analysed for expression of E-cadherin using immunohistochemistry. Statistical analyses were performed to identify possible associations with tumour clinic-histological features and with clinical course and survival. Weak or absent E-cadherin expression was associated with a more invasive histological pattern and with metastasis to the cervical lymph nodes. Uni- and multivariate analyses indicated that weak or undetectable E-cadherin expression is an indicator of shorter disease-free period and shorter survival time. Reduced E-cadherin expression in oral squamous cell carcinoma is associated with more aggressive tumour behaviour and worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249116     DOI: 10.1016/j.oraloncology.2005.07.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  32 in total

1.  The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.

Authors:  Teresa M DesRochers; Yulia Shamis; Addy Alt-Holland; Yasusei Kudo; Takashi Takata; Guangwen Wang; Laurie Jackson-Grusby; Jonathan A Garlick
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

2.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

3.  Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.

Authors:  Dan Zhao; Xiu-Fa Tang; Kai Yang; Ji-Yuan Liu; Xiang-Rui Ma
Journal:  Clin Exp Metastasis       Date:  2012-05-26       Impact factor: 5.150

4.  Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions.

Authors:  Marilena Vered; Irit Allon; Amos Buchner; Dan Dayan
Journal:  Cancer Microenviron       Date:  2009-05-08

5.  E-cadherin expression and prognosis of oral cancer: a meta-analysis.

Authors:  Sheng-Lei Luo; Yong-Gang Xie; Zhen Li; Jia-Hai Ma; Xin Xu
Journal:  Tumour Biol       Date:  2014-02-27

6.  Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.

Authors:  Christina S Kong; Hongbin Cao; Shirley Kwok; Catherine M Nguyen; Richard C Jordan; Veronica G Beaudry; Laura D Attardi; Quynh-Thu Le
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01

7.  Promoter methylation and expression of CDH1 and susceptibility and prognosis of eyelid squamous cell carcinoma.

Authors:  Yong-Qiang Wang; Ye Yuan; Shan Jiang; Hua Jiang
Journal:  Tumour Biol       Date:  2016-01-20

8.  The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Javad Yazdani; Mohhamad Ali Ghavimi; Elahe Jabbari Hagh; Farzin Ahmadpour
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

9.  Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.

Authors:  Carmen J Marsit; Marshall R Posner; Michal D McClean; Karl T Kelsey
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

10.  Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer.

Authors:  Mihai Nita-Lazar; Vikki Noonan; Ivan Rebustini; Janice Walker; A Sue Menko; Maria A Kukuruzinska
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.